MedTrace Logo

Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential

NCT02183285 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 203

Last updated 2014-07-08

No results posted yet for this study

Summary

To determine the tolerability and safety of Pharmaton PHL 00747 soft gelatine capsules and film-coated tablets

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Pharmaton PHL 00747 soft gelatine capsules

DIETARY_SUPPLEMENT

Pharmaton PHL 00747 film-coated tablets

DIETARY_SUPPLEMENT

Placebo film-coated tablets (fct)

DIETARY_SUPPLEMENT

Placebo soft gelatine capsules

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2004-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02183285 on ClinicalTrials.gov